ACTIVE

Novartis Manufacturing

Export PDF

Financial year 2017 · Closed on 31/12/2017

Net result9,9 M €-22,2 %over 1 year

Revenue404,5 M €+8,3 %over 1 year

Equity136,7 M €-64,6 %over 1 year

Workforce1 145,4 ETP+3,3 %over 1 year

Identity

Source · BCE/KBO

Novartis Manufacturing is a Public limited company incorporated in 1962. Its main activity is: Manufacture of pharmaceutical preparations. Its registered office is in Puurs-Sint-Amands. It employs on average 1 145,4 ETP workers (FTE).

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0402.134.977
Incorporation: 01/01/1962
Legal form: Public limited company
Registered office: Rijksweg 14
2870 Puurs-Sint-Amands · FlandreSee on map
Latest accounts: 31/12/2017
Average workforce: 1 145,4 ETP

Activities (NACE)

21201Manufacture of pharmaceutical preparations· main 21201Manufacture of pharmaceutical preparations 24421Aluminium production 20140Manufacture of other organic basic chemicals 20140Manufacture of other organic basic chemicals 24140Manufacture of basic iron and steel and of ferro-alloys+3

Joint committees (3)

Signals

ProfitableSolid equityLow riskPositive cashflowPositive EBITDAHealthy social debtsHigh revenue

Financials

Source · NBB, 20 filings

Trend over 6 financial years

	2017		2016		2015		2011		2009
Income statement
Revenue	404,5 M €	+8.3%	373,3 M €	+1.1%	369,3 M €	+16.6%	316,8 M €	+13.5%	279,2 M €
EBITDA	30,7 M €	-8.8%	33,7 M €	+18.7%	28,4 M €	+13.2%	25,1 M €	+7.4%	23,3 M €
Operating result	15 M €	-15.2%	17,6 M €	+43.6%	12,3 M €	+13.7%	10,8 M €	+10.4%	9,8 M €
Net result	9,9 M €	-22.2%	12,7 M €	+38.5%	9,2 M €	-32.7%	13,7 M €	+410%	2,7 M €
Balance sheet
Equity	136,7 M €	-64.6%	385,8 M €	-0.1%	386,1 M €	-17.4%	467,6 M €	+1540%	28,5 M €
Total assets	262,5 M €	-47.8%	502,5 M €	+2.8%	488,9 M €	-6.9%	525,2 M €	+70.9%	307,4 M €
Cash	216,1 k €	+31.6%	164,3 k €	+137%	69,3 k €	-98.4%	4,3 M €	+619%	594,8 k €
Debts	122,6 M €	+7.6%	113,9 M €	+13.1%	100,7 M €	+90.2%	53 M €	-80.7%	274,7 M €
Other
Workforce	1 145,4 ETP	+3.3%	1 109,3 ETP	+3.2%	1 074,9 ETP	+18.4%	907,9 ETP	+3.3%	879,0 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 250 M€ and 500 M€

See the valuation

Board of directors

Source · NBB, accounts to 31/12/2017

3 active · 16 ended

Active mandates

Dario DRAGO

Director · since 12 mai 2018 · until 25 avril 2024

Active

Ian BELL

Chairman of the board of directors · since 26 avril 2018 · until 25 avril 2024

Active

Edward MCGOUGH

Director · since 24 avril 2018 · until 25 avril 2024

Active

Ended mandates

Dario DRAGO

Director · since 12 mai 2016 · until 26 avril 2018

Ended

Dario DRAGO

Director · since 12 mai 2016 · until 12 mai 2018

Ended

Ian BELL

Chairman of the board of directors · since 12 mai 2016 · until 26 avril 2018

Ended

Edward MCGOUGH

Director · since 12 mai 2012 · until 26 avril 2018

Ended

Full financial information

Source · NBB

	2024	2023	2022	2021	2020	2019
Type of account	Full model	Full model	Full model	Full model	Full model	Full model
Start of the financial year	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020	01/01/2019
Closing of the financial year	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020	31/12/2019
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	30/07/2025	11/07/2024	04/08/2023	27/09/2022	27/07/2021	08/10/2020
General meeting	24/06/2025	25/06/2024	27/06/2023	30/08/2022	29/06/2021	15/07/2020
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 20 filings

Model	Closing	General meeting	Filed	Language	Document
Full model	31/12/2024	24/06/2025	30/07/2025	Dutch	PDF
Full model	31/12/2023	25/06/2024	11/07/2024	Dutch	PDF
Full model	31/12/2022	27/06/2023	04/08/2023	Dutch	PDF
Full model	31/12/2021	30/08/2022	27/09/2022	Dutch	PDF
Full model	31/12/2020	29/06/2021	27/07/2021	Dutch	PDF
Full model	31/12/2019	15/07/2020	08/10/2020	Dutch	PDF
Full modelCorrection	31/12/2018	28/06/2019	09/10/2019	Dutch	PDF
Full model	31/12/2018	28/06/2019	08/08/2019	Dutch	PDF
Full model	31/12/2017	29/06/2018	10/07/2018	Dutch	PDF
Full model	31/12/2016	30/05/2017	21/07/2017	Dutch	PDF
Full model	31/12/2015	12/05/2016	18/08/2016	Dutch	PDF
Full model	31/12/2014	07/08/2015	01/10/2015	Dutch	PDF
Full model	31/12/2013	29/04/2014	09/05/2014	Dutch	PDF
Full model	31/12/2012	28/05/2013	24/06/2013	Dutch	PDF
Full model	31/12/2011	11/06/2012	11/07/2012	Dutch	PDF
Full model	31/12/2010	26/04/2011	24/05/2011	Dutch	PDF
Full model	31/12/2009	27/04/2010	21/05/2010	Dutch	PDF
Full model	31/12/2008	28/04/2009	26/05/2009	Dutch	PDF
Full model	31/12/2007	29/04/2008	21/05/2008	Dutch	PDF
Full model	31/12/2006	24/04/2007	08/05/2007	Dutch	PDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 250 M€ and 500 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2017

3 active · 16 ended

Active mandates

Dario DRAGO

Director · since 12 mai 2018 · until 25 avril 2024

Active

Ian BELL

Chairman of the board of directors · since 26 avril 2018 · until 25 avril 2024

Active

Edward MCGOUGH

Director · since 24 avril 2018 · until 25 avril 2024

Active

Ended mandates

Dario DRAGO

Director · since 12 mai 2016 · until 26 avril 2018

Ended

Dario DRAGO

Director · since 12 mai 2016 · until 12 mai 2018

Ended

Ian BELL

Chairman of the board of directors · since 12 mai 2016 · until 26 avril 2018

Ended

Edward MCGOUGH

Director · since 12 mai 2012 · until 26 avril 2018

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette

Mandates13/08/2025
ONTSLAGEN - BENOEMINGEN
PDF
Mandates14/01/2025
ONTSLAGEN - BENOEMINGEN
PDF
Other02/05/2024
BENAMING
PDF
Mandates23/01/2024
ONTSLAGEN - BENOEMINGEN
PDF
Mandates03/10/2023
ONTSLAGEN - BENOEMINGEN
PDF
Mandates26/06/2023
ONTSLAGEN - BENOEMINGEN
PDF
Mandates10/03/2023
ONTSLAGEN - BENOEMINGEN
PDF
Mandates03/10/2022
ONTSLAGEN - BENOEMINGEN
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

24/06/2025
reconductionKPMG Bedrijfsrevisoren BV — commissaris
18/12/2024
nominationWouter Keymeulen — bestuurder
01/11/2024
nominationWouter Keymeulen — Site Head
25/10/2024
nominationJürg Winters — Site Head ad interim
28/08/2023
nominationHerwig Kapeller — bestuurder
15/05/2023
nominationHerwig Kapeller — gevolmachtigde (Groep A)
01/02/2023
nominationCarl Alexander Brueggemann — gevolmachtigde Groep A
13/09/2022
nominationKPMG Bedrijfsrevisoren BV — commissaris
01/02/2022
nominationFederico Mambretti — bestuurder
01/02/2022
nominationAndrea Majocchi — bestuurder
2017
Annual accounts 20179,9 M €↓
2016
Annual accounts 201612,7 M €↑
2015
Annual accounts 20159,2 M €↓
2011
Annual accounts 201113,7 M €↑
2009
Annual accounts 20092,7 M €↑
2008
Annual accounts 2008246,4 k €
01/01/1962
IncorporationPublic limited company

Novartis Manufacturing

Overview

Identity

Financials

Valuation

Indicative valuation

Board of directors

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline